Photonews Logo Photonews logo
  • Home
  • Pakistan
    • Punjab
    • Sindh
    • Khyber Pakhtunkhwa
    • Azad Jammu Kashmir
    • Balochistan
    • Gilgit – Baltistan
  • World
  • Business
  • Entertainment
  • Videos
    Gen V Season 2 trailer
    Videos

    Gen V Season 2 Trailer Cast, Plot, Premiere Details

    July 26, 2025 3 Min Read
    IShowSpeed Daniel La Belle race
    Videos

    IShowSpeed Beats Daniel La Belle in 40-Meter Race, Hits 41M Subscribers

    June 24, 2025 2 Min Read
    Cardi B new single Outside
    Videos

    Cardi B’s ‘Outside’ Single Sparks Buzz Over Offset and Stefon Diggs

    June 20, 2025 2 Min Read
  • Sports
  • Technology
  • Offbeat
  • Blog
  • Contact
Reading: Mounjaro and Wegovy Named Top Obesity Treatments in New 2025 Guidelines
PhotoNews PakistanPhotoNews Pakistan
Font ResizerAa
Search
  • Home
  • Pakistan
    • Punjab
    • Sindh
    • Khyber Pakhtunkhwa
    • Balochistan
    • Azad Jammu Kashmir
    • Gilgit – Baltistan
  • World
  • Business
  • Entertainment
  • Videos
  • Sports
  • Technology
  • Offbeat
  • Blog
  • Contact
Have an existing account? Sign In
Follow US
© 2022 Photonews. All Rights Reserved.
Mounjaro Wegovy obesity treatment
PhotoNews Pakistan > Tech > Mounjaro and Wegovy Named Top Obesity Treatments in New 2025 Guidelines
Tech

Mounjaro and Wegovy Named Top Obesity Treatments in New 2025 Guidelines

Web Desk
By Web Desk Published October 3, 2025 3 Min Read
Share
Image Credit: SingleCare
SHARE

Leading doctors now recommend Mounjaro and Wegovy as the primary treatments for obesity. On October 2, 2025, the European Association for the Study of Obesity released new guidelines in the journal Nature Medicine. These guidelines emphasise the impressive effectiveness of these medications, noting that they can help reduce the risks of high blood pressure and type 2 diabetes.

Daily Mail UK reported that Dr Andreea Ciudin from the Autonomous University of Barcelona calls them “transformative” for obesity care. “Semaglutide and tirzepatide are so effective, they should be the first choice in most cases,” she says. Consequently, the guidelines shift treatment standards.

Studies show impressive results. Adults using semaglutide (Wegovy, Ozempic) lost an average of 14% of their body weight over a 72-week period. Meanwhile, users of tirzepatide (Mounjaro) shed 20% in the same period. These outcomes make them powerful tools.

Newly published treatment algorithm for the pharmacologic treatment of obesity and its complications, from the European Association for the Study of Obesity (EASO) ⚕️

Semaglutide and tirzepatide are recommended as first line to treat obesity AND to treat underlying… pic.twitter.com/F84l2pdrsY

— Michael Weintraub, MD (@MWeintraubMD) October 2, 2025

Beyond weight loss, the jabs may benefit conditions like chronic kidney disease, neurodegenerative disorders, and mental health issues. However, more research is needed to confirm these effects.

NHS Expansion Plans

In the UK, 16 million adults, 30% of the population, are obese. Yet, only 1.5 million use weight loss jabs, mostly privately at £200 monthly. Health Secretary Wes Streeting, speaking at the Labour Party conference, pledged wider NHS access. “These drugs transform health and confidence,” he said. “We must ensure everyone benefits, not just the wealthy.”

Currently, NHS prescriptions target the most obese patients with multiple conditions. A gradual rollout prevents overwhelming the system, which faces annual obesity costs of £ 11 billion, according to Business Secretary Peter Kyle.

Weight loss jabs Mounjaro and Wegovy are so effective they should be the first treatment for obesity 'in almost all cases', new guidance says https://t.co/skVx2vD6qd

— Daily Mail (@DailyMail) October 3, 2025

The guidelines, crafted by international experts including Professor Barbara McGowan from London’s Guys’ & St Thomas’ Hospital, offer a treatment algorithm. It prioritises Mounjaro and Wegovy for significant weight loss. For lesser goals, alternatives such as liraglutide or phentermine-topiramate may be effective.

McGowan emphasises personalised care. “Treatment must consider complications, comorbidities, and patient goals,” she notes. Socioeconomic factors also matter. The algorithm will evolve in response to new drugs and research.

The guidelines stress early intervention. Untreated obesity leads to costly complications. Thus, investing in jabs now could save healthcare systems billions of dollars. However, high costs pose challenges. Countries must balance access with budgets.

TAGGED:Featured
Share This Article
Facebook Twitter Pinterest Whatsapp Whatsapp LinkedIn Email Copy Link Print
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Advertisement

HBL Saving Made Easy
HBL Saving Made Easy

Recent Posts

US Canada trade talks

Trump Ends US-Canada Trade Talks Over Reagan Ad

Google $2.36 Billion Privacy Lawsuit

Google Users Seek $2.36 Billion After Privacy Trial Verdict

Stephen A. Smith NBA scandal

Stephen A. Smith Suggests Trump Behind NBA Game-Rigging Scandal

Post Archives

More Popular from Photonews

Pakistan Hyperspectral Satellite HS-1
Tech

Pakistan Successfully Launches First Hyperspectral Satellite HS-1

2 Min Read
Cristiano Ronaldo IShowSpeed
Entertainment

Cristiano Ronaldo’s Wink to IShowSpeed Goes Viral

3 Min Read
Diego Pavia’s Mom LSU Victory
Sports

Vanderbilt’s Diego Pavia and Mom Steal Spotlight After LSU Win

3 Min Read
Entertainment

Bon Jovi Forever Tour 2026: Dates, Cities, and New Album

Legendary rock band Bon Jovi has announced their massive Forever Tour for the summer of 2026,…

October 23, 2025
Pakistan

PM Shehbaz Sharif Launches Roshan Maeeshat Bijli Package 

Prime Minister Shehbaz Sharif has announced a new support package for Pakistan's key economic sectors. The…

October 23, 2025
Pakistan

Gold Prices Drop in Pakistan and Globally on October 20, 2025

KARACHI: The price of 24-karat gold dropped by Rs1,400 per tola on Monday, selling at Rs444,900,…

October 20, 2025
Entertainment

Actress Isabelle Tate, Star of ‘9-1-1: Nashville,’ Dies at 23

The entertainment industry has lost a bright young talent. Isabelle Tate, an actress known for her…

October 24, 2025
PhotoNews Pakistan

Always Stay Up to Date

Subscribe to our newsletter to get our newest articles instantly!

Categories

  • World
  • Pakistan
  • Punjab
  • Sindh
  • Khyber Pakhtunkhwa
  • Balochistan
  • Azad Jammu Kashmir

 

  • Top News
  • Business
  • Entertainment
  • Sports
  • Videos
  • Tech
  • Offbeat
  • Blog

© 2024 Phototnews
All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?